Data integrity is one of the main subjects in the life sciences industry. Not surprisingly ISPE will host a two day conference addressing this topic and if you are a member of the European life sciences industry, you’ll most probably be there. Now we’ve entered the digital age, data integrity doesn’t only address the data itself, it also addresses the IT systems that store our data and cloud applications used to calculate data with. How can you make sure that you remain compliant to GxP regulations while adopting a cloud strategy? And do you know what to look out for when implementing SaaS solutions? If the answer is no, you are invited to join us for an intimate discussion on the 6th of October about adopting cloud technology in the life sciences.
Data integrity has been an important subject in the life sciences industry for many years, hence the upcoming Data Integrity Conference Europe in Copenhagen this October by ISPE. Ever since cloud and multiple SaaS solutions started to gain ground within our industry, the discussion on data integrity throughout the pharmaceutical lifecycle has been revived.
GxP regulatory requirements focus on the quality of data and its integrity. In order to be compliant to these regulations, it is wise to incorporate a two stage strategy. First of all, it’s important to identify the risks within the organization. Who can access data, when, where and using what applications, devices and software solutions? Once these factors have been identified, a process to protect critical data can be drafted and shared with all employees that collect, manage or adapt data. The main goal is to educate them on how to work with critical data to reduce errors. Once the process is in place, it can be monitored.
The second aspect of a data integrity strategy has everything to do with the IT systems that are used. One aspect of data being integer and even auditable is to know exactly where it is stored and who can access it. When data is stored in the public cloud – either on servers reserved for your own usage or within a SaaS solution from a third party – the exact location is unknown or at best remains uncertain. Not to mention who has access to the data.
This does of course not mean the cloud is an absolute no-go. On the contrary, the cloud will help the industry being more efficient and even be compliant to multiple security standards. With more and more SaaS solutions being offered to our industry, managers that are responsible for the implementation of systems and procedures to minimize the potential risk to data integrity should know what qualifications to look out for.
During the Data Integrity Conference Europe in Copenhagen, several speakers will talk about the implications of data integrity risks to your organization. In addition to this two day event, Sobi and Iperion invite you to spend an extra day in Copenhagen for an intimate discussion on the 6th of October. In one day you will learn about the impact of the cloud to your organization, what aspects to think of when implementing a SaaS solution and how to adopt SaaS solutions that are not specifically designed for the life sciences industry. Register today and we look forward to meeting you next month.